Free Trial

ICON Public (ICLR) Stock Price, News & Analysis

$287.56
-2.81 (-0.97%)
(As of 10/8/2024 ET)

About ICON Public Stock (NASDAQ:ICLR)

Key Stats

Today's Range
$286.74
$292.31
50-Day Range
$280.48
$330.51
52-Week Range
$221.20
$347.72
Volume
525,616 shs
Average Volume
575,536 shs
Market Capitalization
$23.72 billion
P/E Ratio
34.98
Dividend Yield
N/A
Price Target
$353.60
Consensus Rating
Buy

Company Overview

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

ICON Public Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
90th Percentile Overall Score

ICLR MarketRank™: 

ICON Public scored higher than 90% of companies evaluated by MarketBeat, and ranked 116th out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ICON Public has received a consensus rating of Buy. The company's average rating score is 3.08, and is based on 11 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ICON Public has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about ICON Public's stock forecast and price target.
  • Earnings Growth

    Earnings for ICON Public are expected to grow by 15.20% in the coming year, from $14.54 to $16.75 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ICON Public is 34.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.46.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ICON Public is 34.98, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 127.87.

  • Price to Earnings Growth Ratio

    ICON Public has a PEG Ratio of 1.32. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    ICON Public has a P/B Ratio of 2.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about ICON Public's valuation and earnings.
  • Percentage of Shares Shorted

    1.82% of the float of ICON Public has been sold short.
  • Short Interest Ratio / Days to Cover

    ICON Public has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ICON Public has recently decreased by 3.87%, indicating that investor sentiment is improving.
  • Dividend Yield

    ICON Public does not currently pay a dividend.

  • Dividend Growth

    ICON Public does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.82% of the float of ICON Public has been sold short.
  • Short Interest Ratio / Days to Cover

    ICON Public has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ICON Public has recently decreased by 3.87%, indicating that investor sentiment is improving.
  • News Sentiment

    ICON Public has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for ICON Public this week, compared to 3 articles on an average week.
  • Search Interest

    3 people have searched for ICLR on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added ICON Public to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ICON Public insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    44.00% of the stock of ICON Public is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    95.61% of the stock of ICON Public is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ICON Public's insider trading history.
Receive ICLR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICON Public and its competitors with MarketBeat's FREE daily newsletter.

ICLR Stock News Headlines

Icon PLC (ICLR) Trading 3.72% Higher on Oct 2
[SHOCKING] Crypto Document Leak…
The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.
ICON draws bullish view at Leerink on business model
Implied Volatility Surging for ICON (ICLR) Stock Options
See More Headlines

ICLR Stock Analysis - Frequently Asked Questions

ICON Public's stock was trading at $283.07 on January 1st, 2024. Since then, ICLR stock has increased by 1.6% and is now trading at $287.56.
View the best growth stocks for 2024 here
.

ICON Public Limited (NASDAQ:ICLR) announced its quarterly earnings data on Wednesday, July, 24th. The medical research company reported $3.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.68 by $0.07. ICON Public's revenue for the quarter was up 4.1% on a year-over-year basis.

ICON Public subsidiaries include these companies: PRA Health Sciences, MedPass International, MeDiNova Research, MolecularMD, Mapi Group, Clinical Research Management, PMG Research, and more.

Top institutional investors of ICON Public include Cullen Investment Group LTD. (0.01%) and Sara Bay Financial.

Shares of ICLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that ICON Public investors own include Pfizer (PFE), Gilead Sciences (GILD), Visa (V), NVIDIA (NVDA), CVS Health (CVS), UnitedHealth Group (UNH) and Alibaba Group (BABA).

Company Calendar

Last Earnings
7/24/2024
Today
10/08/2024
Next Earnings (Confirmed)
10/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
Business Services
Current Symbol
NASDAQ:ICLR
Employees
41,100
Year Founded
1990

Price Target and Rating

Average Stock Price Target
$353.60
High Stock Price Target
$383.00
Low Stock Price Target
$315.00
Potential Upside/Downside
+23.0%
Consensus Rating
Buy
Rating Score (0-4)
3.08
Research Coverage
12 Analysts

Profitability

Net Income
$612.34 million
Pretax Margin
9.05%

Debt

Sales & Book Value

Annual Sales
$8.33 billion
Cash Flow
$18.89 per share
Book Value
$112.02 per share

Miscellaneous

Free Float
46,197,000
Market Cap
$23.72 billion
Optionable
Optionable
Beta
1.22

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:ICLR) was last updated on 10/8/2024 by MarketBeat.com Staff
From Our Partners